Literature DB >> 31399380

A new frontier in ARDS trials: phenotyping before randomisation.

Carolyn M Hendrickson1, Carolyn S Calfee2.   

Abstract

Mesh：

Year:  2019        PMID： 31399380     DOI： 10.1016/S2213-2600(19)30175-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  4 in total

1.  Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury.

Authors:  Konrad Peukert; Mario Fox; Susanne Schulz; Caroline Feuerborn; Stilla Frede; Christian Putensen; Hermann Wrigge; Beate Mareike Kümmerer; Sascha David; Benjamin Seeliger; Tobias Welte; Eicke Latz; Dennis Klinman; Christoph Wilhelm; Folkert Steinhagen; Christian Bode
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405

2.  External Validation of an Acute Respiratory Distress Syndrome Prediction Model Using Radiology Reports.

Authors:  Anoop Mayampurath; Matthew M Churpek; Xin Su; Sameep Shah; Elizabeth Munroe; Bhakti Patel; Dmitriy Dligach; Majid Afshar
Journal:  Crit Care Med       Date:  2020-09       Impact factor: 9.296

Review 3.  Acute respiratory distress syndrome.

Authors:  Nuala J Meyer; Luciano Gattinoni; Carolyn S Calfee
Journal:  Lancet       Date:  2021-07-01       Impact factor: 79.321

4.  Early Changes Over Time in the Radiographic Assessment of Lung Edema Score Are Associated With Survival in ARDS.

Authors:  Matthieu Jabaudon; Jules Audard; Bruno Pereira; Samir Jaber; Jean-Yves Lefrant; Raiko Blondonnet; Thomas Godet; Emmanuel Futier; Céline Lambert; Jean-Etienne Bazin; Julie A Bastarache; Jean-Michel Constantin; Lorraine B Ware
Journal:  Chest       Date:  2020-07-10       Impact factor: 9.410
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.